心臓　56/5　2024年5月号

出版社： 日本医学出版
発行日： 2024-05-15
分野： 臨床医学：内科  >  雑誌
ISSN： 05864488
雑誌名：
電子書籍版： 2024-05-15
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,200 円(税込)

購入する

目次

  • Open HEART
    　単数を表すthey

    HEART’s Selection
    　2024年版不整脈治療ガイドラインを語る
    　　新ガイドラインが発刊されるときは、もう新ガイドラインは古くなる？！
    　座談会　2024年版不整脈治療ガイドラインを語る
    　　―2024年JCS/JHRSガイドラインフォーカスアップデート版　不整脈治療―

    [連載]HEART’s Column
    　Authorが語る日本発のクリニカル・エビデンス：論文の解説と発表後の展望
    　　Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

    [連載]HEART’s Up To Date
    　循環器医が知っておくべき最新のエビデンス
    　ATTR心アミロイドーシス治療薬に関する最新の動向

    HEART’s Original
    [臨床研究]
    　ATTR野生型心アミロイドーシス患者の長期的12誘導心電図四肢誘導R波高変化と
    　　心エコー図指標変化の関連

    [Editorial Comment]
    　小林論文に対するEditorial　Comment

    [臨床研究]
    　心不全患者のセルフモニタリング向上に向けての遠隔看護介入

    [症例]
    　頻脈誘発性心筋症による薬物治療抵抗性心不全に対してIMPELLA CP®を用いて良好な転帰を得た１例

    [症例]
    　ベバシズマブを含む特異的化学療法により予後改善を認めた乳癌由来肺腫瘍血栓性微小血管症の1例

    [Editorial Comment]
    　寺中論文に対するEditorial　Comment

    [症例]
    　ニッケルアレルギーを同定することで薬剤溶出性ステント留置を回避した非ST上昇型心筋梗塞の１例

    [Editorial Comment]
    　添田論文に対するEditorial　Comment

    [Editorial Comment]
    　添田論文に対するEditorial　Comment

    [症例]
    　冠動脈バイパス術後狭心症再発症例に対する低侵襲冠動脈バイパス術の1例

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【HEART' s Selection】

P.438 掲載の参考文献
1) Aonuma K, Ando K, Kusano K, et al ; HINODE Investigators : Primary results from the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE). ESC Heart Fail 2022 ; 9 : 1584-1596
 
2) The MADIT-ICD Benefit Calculator : https://redcap.urmc.rochester.edu/redcap/surveys/index.php?s=3H888TJ8N7
 
3) Seattle Proportional Risk Model : https://depts.washington.edu/sprm/about.php
 
4) Wazni OM, Dandamudi G, Sood N, et al ; STOP AF First Trial Investigators : Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med 2021 ; 384 : 316-324
 
5) Andrade JG, Wells GA, Deyell MW, et al ; EARLY-AF Investigators : Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med 2021 ; 384 : 305-315
 
6) Kuniss M, Pavlovic N, Velagic V, et al ; Cryo-FIRST Investigator : Cryoballoon ablation vs. antiarrhythmic drugs : first-line therapy for patients with paroxysmal atrial fibrillation. Europace 2021 ; 23 : 1033-1041
 
7) Kirchhof P, Camm AJ, Goette A, et al ; EAST-AFNET 4 Trial Investigators : Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med 2020 ; 383 : 1305-1316
 
8) Kim JY, Park HS, Park HW, et al : Clinical outcomes of rhythm control strategies for asymptomatic atrial fibrillation according to the quality-of-life score : the CODE-AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) registry. J Am Heart Assoc 2022 ; 11 : e025956
 
9) Kuck KH, Lebedev DS, Mikhaylov EN, et al : Catheter ablation or medical therapy to delay progression of atrial fibrillation : the randomized controlled atrial fibrillation progression trial (ATTEST). Europace 2021 ; 23 : 362-369
 
10) Andrade JG, Deyell MW, Macle L, et al ; EARLY-AF Investigators : Progression of atrial fibrillation after cryoablation or drug therapy. N Engl J Med 2023 ; 388 : 105-116
PubMed
11) Packer DL, Piccini JP, Monahan KH, et al ; CABANA Investigators : Ablation versus drug therapy for atrial fibrillation in heart failure : results from the CABANA trial. Circulation 2021 ; 143 : 1377-1390
 
12) Marrouche NF, Brachmann J, Andresen D, et al ; CASTLE-AF Investigators : Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018 ; 378 : 417-427
 
13) Okumura K, Tomita H, Nakai M, et al ; J-RISK AF Research Group : Risk factors associated with ischemic stroke in Japanese patients with nonvalvular atrial fibrillation. JAMA Netw Open 2020 ; 3 : e202881
 
14) Okumura K, Tomita H, Nakai M, et al ; J-RISK AF Research Group : A novel risk stratification system for ischemic stroke in Japanese patients with non-valvular atrial fibrillation. Circ J 2021 ; 85 : 1254-1262
 
15) Yamauchi T, Okumura Y, Nagashima K, et al : External validation of the HELT-E2S2 score in Japanese patients with nonvalvular atrial fibrillation-a pooled analysis of the RAFFINE and SAKURA registries. Circ J 2023 ; 87 : 1777-1787
 
16) Kotecha D, Bunting KV, Gill SK, et al ; Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) Team : Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life : the RATE-AF randomized clinical trial. JAMA 2020 ; 324 : 2497-2508
 
17) 日本循環器学会/日本不整脈心電学会 : 2020年改訂版 不整脈薬物治療ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/01/JCS2020_Ono.pdf
 
18) Kotecha D, Holmes J, Krum H, et al ; Beta-Blockers in Heart Failure Collaborative Group : Efficacy of β blockers in patients with heart failure plus atrial fibrillation : an individual-patient data meta-analysis. Lancet 2014 ; 384 : 2235-2243
 

【連載】

P.443 掲載の参考文献
1) Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H ; AFIRE Investigators : Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. N Engl J Med 2019 ; 381 : 1103-1113
 
2) Tanigawa T, Kaneko M, Hashizume K, et al : Model-based dose selection for phase III rivaroxaban study in Japanese patients with non-valvular atrial fibrillation. Drug Metab Pharmacokinet 2013 ; 28 : 59-70
 
3) Kaikita K, Yasuda S, Akao M, et al : Bleeding and Subsequent Cardiovascular Events and Death in Atrial Fibrillation With Stable Coronary Artery Disease : Insights From the AFIRE Trial. Circ Cardiovasc Interv 2021 ; 14 : e010476
PubMed
4) Naito R, Miyauchi K, Yasuda S, et al : Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease : A Post Hoc Secondary Analysis of the AFIRE Trial. JAMA Cardiol 2022 ; 7 : 787-794
 
5) Matsuzawa Y, Kimura K, Yasuda S, et al : Antithrombotic Therapy for Atrial Fibrillation and Coronary Artery Disease in Patients With Prior Atherothrombotic Disease : A Post Hoc Analysis of the AFIRE Trial. J Am Heart Assoc 2021 ; 10 : e020907
 
6) Kawakami S, Yasuda, S, Ogawa H : Antithrombotic therapy in atrial fibrillation patients with coronary artery disease : shifting paradigm to a "less is more" concept regimen. J Cardiol 2020 ; 76 : 35-43
 
7) Nakano M, Yasuda S, Hasebe H, et al : Inhibitory effect of rivaroxaban on protease-activated receptor-2 in circulating neutrophil among patients with atrial fibrillation. Int J Cardiol Heart Vasc 2024 (In Press)
 

【HEART' s Original】

P.453 掲載の参考文献
1) 日本循環器学会 : 2020年版 心アミロイドーシス診療ガイドライン. https://www.j-circ.or.jp/cms/wpcontent/uploads/2020/02/JCS2020_Kitaoka.pdf (cited 2021 Nov 10)
 
2) Bozkurt B, Coats AJ, Tsutsui H, et al : Universal definition and classification of heart failure. A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and writing committee of the Universal Definition of Heart Failure. J Card Fail 2021 ; 27 : 387-413
 
3) Cyrille NB, Goldsmith J, Alvarez J, Maurer MS : Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis. Am J Cardiol 2014 ; 114 : 1089-1093
 
4) Kristen AV, Perz JB, Schonland SO, et al : Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail 2007 ; 9 : 617-624
 
5) Gillmore JD, Maurer MS, Falk RH, et al : Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016 ; 133 : 2404-2412
 
6) Castano A, Haq M, Narotsky DL, et al : Multicenter study of planar technetium 99m pyrophosphate cardiac imaging : predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 2016 ; 1 : 880-889
 
7) Maurer MS, Schwartz JH, Gundapaneni B, et al : ATTR-ACT Study Investigators. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 2018 ; 379 : 1007-1016
 
P.454 掲載の参考文献
1) Takahashi K, Sasaki D, Yamashita M, et al : Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis. J Nucl Cardiol 2022 ; 29 : 3126-3136
 
2) Kitaoka H, Izumi C, Izumiya Y, et al : JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis. Circ J 2020 ; 84 : 1610-1671
 
3) Hamada M, Shigematsu Y, Kawakami H, et al : Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy : its relation to endothelin-I, natriuretic peptides and noradrenaline. Clin Sci (Lond) 1998 ; 94 : 21-28
 
4) Higashi H, Inaba S, Inoue K, et al : Pseudo-electrocardiographic regression of left ventricular hypertrophy in aortic stenosis : concomitant cardiac amyloidosis. Eur Heart J Cardiovasc Imaging 2021 ; 22 : e155
PubMed
P.464 掲載の参考文献
1) 日本循環器学会・編 : 心不全療養指導士認定試験ガイドブック 改訂第2版. 東京 : 南江堂 ; 2022. p.2-4
 
2) 日本循環器学会・編 : 心不全療養指導士認定試験ガイドブック 改訂第2版. 東京 : 南江堂 ; 2022. p.5
 
3) 服部容子, 多留ちえみ, 宮脇郁子 : 心不全のセルフモニタリングの概念分析. 日本看護科学会誌 2010 ; 30 : 74-82
 
4) 日本循環器学会/日本心不全学会 : 急性・慢性心不全診療ガイドライン (2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h.pdf (cited 2022 Jan 6)
 
5) 石橋信江, 東ますみ, 藤永新子, 西村治彦 : 高齢慢性心不全患者のセルフモニタリングを促す遠隔看護介入モデルの実践と有用性の検証. 日本看護科学会誌 2018 ; 38 : 219-228
 
6) Inglis SC, Clark RA, Dierckx R, et al : Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev 2015 ; 2015 : CD007228
 
7) 石川県心臓病地域連携推進協議会・石川県心不全メディカルスタッフネットワーク・編 : 石川県心不全地域連携パス・手帳 (制作 2022年2月)
 
8) Kanda Y : Investigation of the freely-available easy-to-use software "EZR" (Easy R) for medical statistics. Bone Marrow Transplant 2013 ; 48 : 452-458
 
9) 藤田三恵, 川島和代, 諸江由紀子 : 慢性疾患患者が食事を改善し維持に至る認識の変化の過程. 日本看護研究学会雑誌 2008 ; 31 : 39-48
 
10) 高瀬広詩, 松尾善美, 柳澤幸夫, ほか : 在宅高齢心不全患者における運動の実態. 理学療法科学 2013 ; 28 : 583-587
 
P.470 掲載の参考文献
1) Nerheim P, Birger-Botkin S, Piracha L, Olshansky B : Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 2004 ; 110 : 247-252
 
2) Ellis ER, Josephson ME : What About Tachycardia-induced Cardiomyopathy? Arrhythm Electrophysiol Rev 2013 ; 2 : 82-90
 
3) Volle, K, Delmas C, Rollin A, et al : Successful Reversal of Severe Tachycardia-Induced Cardiomyopathy with Cardiogenic Shock by Urgent Rhythm or Rate Control : Only Rhythm and Rate Matter. J Clin Med 2021 ; 10 : 4504
PubMed
4) Baran DA, Grines CL, Bailey S, et al : SCAI Clinical Expert Consensus Statement on the Classification of Cardiogenic Shock : this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 2019 ; 94 : 29-37
 
5) Huizar JF, Ellenbogen KA, Tan AY, Kaszala K : Arrhythmia-Induced Cardiomyopathy : JACC State-of-the-Art Review. J Am Coll Cardiol 2019 ; 73 : 2328-2344
 
6) Hekimian G, Paulo N, Waintraub X, et al : Arrhythmia-induced cardiomyopathy : A potentially reversible cause of refractory cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation. Heart Rhythm 2021 ; 18 : 1106-1112
 
7) Lee JW, Ahn HJ, Yoo YH, et al : Extracorporeal CPR and intra-aortic balloon pumping in tachycardia-induced cardiomyopathy complicating cardiac arrest. Am J Emerg Med 2017 ; 35 : 1208. e5-1208. e7
 
8) Kamada K, Kubo T, Sada M, et al : Successful recovery of tachycardia-induced cardiomyopathy with severely depressed left ventricular systolic function by catheter ablation with mechanical hemodynamic support : a case report. Clin Case Rep 2016 ; 14 : 232-235
 
9) Pieri M, Sorrentino T, Oppizzi M, et al : The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock. J Interv Cardiol 2018 ; 31 : 717-724
 
10) O'Neill WW, Kleiman NS, Moses J, et al : A prospective, randomized clinical trial of hemodynamic support with Impella 2. 5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention : the PROTECT II study. Circulation 2012 ; 126 : 1717-1727
 
11) Karami M, den Uil CA, Ouweneel DM, et al : Mechanical circulatory support in cardiogenic shock from acute myocardial infarction : Impella CP/5.0 versus ECMO. Eur Heart J Acute Cardiovasc Care 2020 ; 9 : 164-172
 
12) 桃原哲也 : ショック, 心不全を伴う急性心筋梗塞に対する冠血行再建術. 冠疾患誌 2016 ; 22 : 175-180
 
P.477 掲載の参考文献
1) von Herbay A, Illes A, Waldherr R, Otto HF : Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 1990 ; 66 : 587-592
 
2) Price LC, Seckl MJ, Dorfmuller P, Wort SJ : Tumoral pulmonary hypertension. Eur Respir Rev 2019 ; 28 : 180065
PubMed
3) Godbole RH, Saggar R, Kamangar N : Pulmonary tumor thrombotic microangiopathy : a systematic review. Pulm Circ 2019 ; 9 : 2045894019851000
PubMed
4) Uruga H, Fujii T, Kurosaki A, et al : Pulmonary tumor thrombotic microangiopathy : a clinical analysis of 30 autopsy cases. Intern Med 2013 ; 52 : 1317-1323
 
5) 櫨木暢子, 小林和幸, 山本正嗣, ほか : 原発不明癌によるPulmonary tumor thrombotic microangiopathyの1症例. 日呼吸会誌 2009 ; 47 : 1030-1035
 
6) Miyano S, Izumi S, Takeda Y, et al : Pulmonary tumor thrombotic microangiopathy. J Clin Oncol 2007 ; 25 : 597-599
 
7) 林一樹, 篠原尚吾, 末廣篤, ほか : 肺腫瘍血栓性微小血管症 (PTTM) による呼吸不全のため急激に死の転機をたどった舌下腺腺様嚢胞癌症例. 頭頸部外科 2017 ; 27 : 117-121
 
8) Masson RG, Krikorian J, Luki P, et al : Pulmonary microvascular cytology in the diagnosis of lymphangitic carcinomatosis. N Engl J Med 1989 ; 321 : 71-76
 
9) Abati A, Landucci D, Danner RL, Solomon D : Diagnosis of pulmonary microvascular metastases by cytologic evaluation of pulmonary artery catheter-derived blood specimens. Hum Pathol 1994 ; 25 : 257-262
 
10) 馬場雅之, 藤瀬悠太, 新野大介, 岩崎啓介 : 乳癌術後経過中に発症したpulmonary tumor thrombotic microangiopathyの1例. 日臨外会誌 2021 ; 82 : 38-45
 
11) Aoyama D, Fukui S, Hirata H, et al : Crizotinib for ROS1-rearranged lung cancer and pulmonary tumor thrombotic microangiopathy under venoarterial extracorporeal membrane oxygenation. Pulm Circ 2022 ; 12 : e12047
PubMed
12) Higo K, Kubota K, Takeda A, et al : Successful Antemortem Diagnosis and Treatment of pulmonary Tumor Thrombotic Microangiopathy. Intern Med 2014 ; 53 : 2595-2599
 
P.479 掲載の参考文献
1) Price LC, Seckl MJ, Dorfmuller P, Wort SJ, et al : Tumoral pulmonary hypertension. Eur Respir Rev 2019 ; 28 : 180065
PubMed
2) Kimura A, Yamada A, Oshi M, et al : Dramatic Improvement of Pulmonary Tumor Thrombotic Microangiopathy in a Breast Cancer Patient Treated With Bevacizumab. World J Oncol 2023 ; 14 : 575-579
 
P.484 掲載の参考文献
1) Kimura K, Kimura T, Ishihara M, et al ; Japanese Circulation Society Joint Working Group : JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome. Circ J 2019 ; 83 : 1085-1196
 
2) 日本皮膚科学会接触皮膚炎診療ガイドライン改定委員会 : 接触皮膚炎診療ガイドライン 2020. 日皮会誌 2020 ; 130 : 523-567
 
3) Saito T, Hokimoto S, Oshima S, et al : Metal allergic reaction in chronic refractory in-stent restenosis. Cardiovasc Revasc Med 2009 ; 10 : 17-22
 
4) Giraldo-Tugores M, Sanmartin-Fernandez M, Fernandez-Lozano C, et al : Allergic contact dermatitis from nickel and coronary aneurysm. Contact Dermatitis 2023 ; 88 : 480-482
 
5) Thyssen JP, Engkilde K, Menne T, et al : No association between metal allergy and cardiac in-stent restenosis in patients with dermatitis-results from a linkage study. Contact Dermatitis 2011 ; 64 : 138-141
 
6) Romero-Brufau S, Best PJM, Holmes DR, et al : Outcomes After Coronary Stent Implantation in Patients With Metal Allergy. Circ Cardiovasc Interv 2012 ; 5 : 220-226
 
7) 江田匡仁, 手嶋悠人, 須賀一将, ほか : アレルギー反応が原因と思われるステント内再狭窄症に対する冠状動脈バイパス術の1例. 胸部外科 2016 ; 69 : 545-547
 
8) Nakamura M, Isawa T, Nakamura S, et al : Drug-coated balloon for the treatment of small vessel coronary artery disease- a randomized non-inferiority trial. Circ J 2023 ; 87 : 287-295
 
P.486 掲載の参考文献
1) Mahler V, Geier J, Schnuch A : Current trends in patch testing-new data from the German Contact Dermatitis Research Group (DKG) and the Information Network of Departments of Dermatology (IVDK). J Dtsch Dermatol Ges 2014 ; 12 : 583-592
 
2) Hu FW, Chang S, Li Q, et al : Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With Drug-Coated Balloon-Only Strategy in de novo Lesions of Large Coronary Arteries. Front Cardiovasc Med 2022 ; 9 : 882303
 
P.487 掲載の参考文献
1) 日本接触皮膚炎研究班 : Japanese standard allergens 2008 (JSA 2008) 調査データ (アレルゲン別_陽性率). https://www.jscia.org/img/pdf/jsa2008.pdf (cited 2024 Mar 25)
 
2) Saito T, Hokimoto S, Oshima S, et al : Metal allergic reaction in chronic refractory in-stent restenosis. Cardiovasc Revasc Med 2009 ; 10 : 17-22
 
3) Scheller B, Ohlow MA, Ewen S, et al : Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction : the randomised PEPCAD NSTEMI trial. EuroIntervention 2020 ; 15 : 1527-1533
PubMed
4) Jolly SS, Yusuf S, Carins J, et al : Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL) : a randomised, parallel group, multicentre trial. Lancet 2011 ; 377 : 1409-1420
 
P.491 掲載の参考文献
1) 川崎有亮, 小澤達也, 末永悦郎 : 腋窩動脈を中枢側吻合部として用いたMICS-CABGの1例. 日心臓血管外会誌 2021 ; 50 : 73-77
 
2) Bonatti J, Hangler H, Oturanlar D, et al : Beating heart axillocoronary bypass for management of the untouchable ascending aorta in coronary artery bypass grafting. Eur J Cardiothorac Surg 1999 ; 16 (Suppl 2) : S18-23
 
3) 坂口太一 : MICS-CABGの現況と展望. 冠疾患誌 2016 ; 22 : 65-69
 

書評

最近チェックした商品履歴

Loading...